Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Taniguchi

Showing results (111-120 of 171) with videos related to

Pageof 18
Sort By:
Respiratory Medicine|September 21, 2012
Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patientsTomonori Tanaka, Kyoko Otani, Ryoko Egashira, et al.
Respiratory Investigation|September 8, 2015
All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosisTakashi Ogura, Arata Azuma, Yoshikazu Inoue, et al.
Onkologie|December 5, 2012
Prognosis in patients with non-small cell lung cancer who received erlotinib treatment and subsequent dose reduction due to skin rashNaoki Takashima, Tomoki Kimura, Naohiro Watanabe, et al.
Respiratory Medicine|September 29, 2018
Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosisRyo Teramachi, Yasuhiro Kondoh, Kensuke Kataoka, et al.
Respiratory Medicine|October 9, 2009
Serum KL-6 in fibrotic NSIP: Correlations with physiologic and radiologic parametersKoji Sakamoto, Hiroyuki Taniguchi, Yasuhiro Kondoh, et al.
The Clinical Respiratory Journal|July 21, 2021
Comparison between tools for measuring breathlessness: Cross-sectional validation of the Japanese version of the Dyspnoea-12Koichi Nishimura, Toru Oga, Kazuhito Nakayasu, et al.
Respiratory Care|December 12, 2013
Endurance time is the most responsive exercise measurement in idiopathic pulmonary fibrosisShinichi Arizono, Hiroyuki Taniguchi, Koji Sakamoto, et al.
The European Respiratory Journal|January 20, 2018
A scoring system to predict the elevation of mean pulmonary arterial pressure in idiopathic pulmonary fibrosisTaiki Furukawa, Yasuhiro Kondoh, Hiroyuki Taniguchi, et al.
Respiratory Investigation|November 2, 2015
Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in JapanYasuhiro Kondoh, Hiroyuki Taniguchi, Masahito Ebina, et al.
Respiratory Research|November 1, 2011
Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatmentArata Azuma, Yoshio Taguchi, Takashi Ogura, et al.
Pageof 18

Showing results (111-120 of 171) with videos related to

Sort By:
Pageof 18
Respiratory Medicine|September 21, 2012
Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patientsTomonori Tanaka, Kyoko Otani, Ryoko Egashira, et al.
Respiratory Investigation|September 8, 2015
All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosisTakashi Ogura, Arata Azuma, Yoshikazu Inoue, et al.
Onkologie|December 5, 2012
Prognosis in patients with non-small cell lung cancer who received erlotinib treatment and subsequent dose reduction due to skin rashNaoki Takashima, Tomoki Kimura, Naohiro Watanabe, et al.
Respiratory Medicine|September 29, 2018
Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosisRyo Teramachi, Yasuhiro Kondoh, Kensuke Kataoka, et al.
Respiratory Medicine|October 9, 2009
Serum KL-6 in fibrotic NSIP: Correlations with physiologic and radiologic parametersKoji Sakamoto, Hiroyuki Taniguchi, Yasuhiro Kondoh, et al.
The Clinical Respiratory Journal|July 21, 2021
Comparison between tools for measuring breathlessness: Cross-sectional validation of the Japanese version of the Dyspnoea-12Koichi Nishimura, Toru Oga, Kazuhito Nakayasu, et al.
Respiratory Care|December 12, 2013
Endurance time is the most responsive exercise measurement in idiopathic pulmonary fibrosisShinichi Arizono, Hiroyuki Taniguchi, Koji Sakamoto, et al.
The European Respiratory Journal|January 20, 2018
A scoring system to predict the elevation of mean pulmonary arterial pressure in idiopathic pulmonary fibrosisTaiki Furukawa, Yasuhiro Kondoh, Hiroyuki Taniguchi, et al.
Respiratory Investigation|November 2, 2015
Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in JapanYasuhiro Kondoh, Hiroyuki Taniguchi, Masahito Ebina, et al.
Respiratory Research|November 1, 2011
Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatmentArata Azuma, Yoshio Taguchi, Takashi Ogura, et al.
Pageof 18